Status:
COMPLETED
Application of LLM Care and Related Affective Computing Systems on People With Parkinson's Disease
Lead Sponsor:
Aristotle University Of Thessaloniki
Conditions:
Parkinson Disease
Eligibility:
All Genders
50-85 years
Phase:
NA
Brief Summary
The study is an adaptation of the Long Lasting Memories (LLM) (NCT02267499) and the subsequent LLM Care (NCT02313935) projects in patients with Parkinson's Disease (PD). The study aims to examine the ...
Detailed Description
Parkinson's Disease (PD) is a highly prevalent chronic neurodegenerative disease of the central nervous system, with both motor and non-motor symptoms, having a high impact on the quality of life of t...
Eligibility Criteria
Inclusion
- Age 50 years and older
- Native level speakers of the Greek language
- Able to commit for the required intervention time
- No significant mobility problems (upper or lower limbs)
- Normal or corrected to normal visual and auditory acuity
- In case of any chronic diseases, such as hypertension, diabetes, etc., there should be advice from the competent doctor
- No serious cardiovascular problems
- Mild physical activity supervised by a physician
- Stable medication so as not to affect the patient's functionality from Parkinson's motor symptoms (e.g., stiffness, dyskinesia, restlessness, gait disorder and instability, etc.)
Exclusion
- History of serious neurological diseases or psychiatric illness
- Recent (within 6 months) history of stroke, transient ischemic stroke episode, traumatic brain injury, ALS, multiple sclerosis
- Substance abuse
- Use of acetylcholinesterase inhibitor is not excluded, as long as its use has started 4 months before joining the study, and is stable during its course study remains constant
- Significant communication disorders
- Simultaneous enrolment in other studies
- Patients suspected of not being able or willing to cooperate or comply with study protocol requirements
- Statin users may be excluded unless during the study the use is constant
- Patients diagnosed in stages 4 and 5 of the disease, or have undergone surgical treatment
Key Trial Info
Start Date :
March 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2018
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT04426903
Start Date
March 1 2017
End Date
July 1 2018
Last Update
July 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Laboratory of Medical Physics, AUTH
Thessaloniki, Greece